Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Generation of functional mesothelial cells from human iPSCs that restore peritoneal integrity in experimental peritoneal injury.

Stem cell research & therapy·2026

Same author

Temporal AI model predicts drivers of cell state trajectories across human aging.

bioRxiv : the preprint server for biology·2026

Same author

Heart failure-specific cardiac fibroblasts contribute to cardiac dysfunction via the MYC-CXCL1-CXCR2 axis.

Nature cardiovascular research·2025

Same author

Inhibition of Scarb1 on Endothelial Cells Attenuates Pressure Overload-Induced Heart Failure Progression.

JACC. Basic to translational science·2025

Same author

Sipa1 Drives a Maladaptive Fibroblast-Myeloid Axis After Myocardial Infarction.

Circulation research·2025

Same author

Establishment and characterization of an induced pluripotent stem cell line from a Japanese cystic fibrosis patient with homozygous 1540del10 CFTR mutation.

Genes & diseases·2025

Search research articles

Related Experiment Video

Updated: May 4, 2026

Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells

Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells

Published on: June 28, 2013

Distinct iPS Cells Show Different Cardiac Differentiation Efficiency.

Yohei Ohno¹, Shinsuke Yuasa¹, Toru Egashira¹

¹Department of Cardiology, Keio University School of Medicine, Tokyo 160-8582, Japan.

Stem Cells International

|December 25, 2013

Summary

High-quality induced pluripotent stem (iPS) cells show superior cardiomyocyte differentiation for regenerative medicine. Careful characterization of iPS cell lines is crucial before clinical application to ensure safety and efficacy.

More Related Videos

High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry

High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry

Published on: September 23, 2014

Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization

Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization

Published on: January 17, 2020

Related Experiment Videos

Last Updated: May 4, 2026

Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells

Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells

Published on: June 28, 2013

High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry

High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry

Published on: September 23, 2014

Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization

Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization

Published on: January 17, 2020

Area of Science:

Stem Cell Biology
Regenerative Medicine
Cardiovascular Research

Background:

Patient-specific induced pluripotent stem (iPS) cells offer a promising alternative to embryonic stem (ES) cells for regenerative medicine, circumventing ethical and immunological concerns.
Advancements in iPS cell generation have improved efficiency, safety, and versatility, yet the suitability of different iPS cell types for clinical applications remains unclear.

Purpose of the Study:

To evaluate the differentiation potential, kinetics, and efficiency of various iPS cell lines into cardiomyocytes in vitro.
To characterize the properties of iPS cell-derived cardiomyocytes.

Main Methods:

Generation of patient-specific induced pluripotent stem (iPS) cells from somatic cells using transcription factors.
In vitro differentiation of multiple iPS cell lines into cardiomyocytes.
Assessment of differentiation efficiency, time course, and quality of derived cardiomyocytes.

Main Results:

High-quality iPS cell lines demonstrated significantly better cardiomyocyte differentiation efficiency and kinetics compared to low-quality iPS cells.
Low-quality iPS cells exhibited minimal to no differentiation into cardiomyocytes.
Variability in cardiac differentiation potential and potential safety concerns were observed among different iPS cell lines.

Conclusions:

The quality of iPS cells directly impacts their potential for cardiomyocyte differentiation.
Thorough characterization of newly established iPS cell lines is essential before their application in cardiac regenerative medicine.
This research highlights the importance of quality control for iPS cell-based therapies.